Kazia Therapeutics Ltd KZIA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:42 PM EDT
5.83quote price arrow up+0.11 (+1.83%)
Volume
10,711
52 week range
5.01 - 12.28
Loading...
  • Open6.00
  • Day High6.00
  • Day Low5.70
  • Prev Close5.72
  • 52 Week High12.28
  • 52 Week High Date11/03/21
  • 52 Week Low5.01
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap78.06M
  • Shares Out13.39M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta2.39
  • YTD % Change-30.76

KEY STATS

  • Open6.00
  • Day High6.00
  • Day Low5.70
  • Prev Close5.72
  • 52 Week High12.28
  • 52 Week High Date11/03/21
  • 52 Week Low5.01
  • 52 Week Low Date05/12/22
  • Market Cap78.06M
  • Shares Out13.39M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta2.39
  • YTD % Change-30.76

RATIOS/PROFITABILITY

  • EPS (TTM)-0.83
  • P/E (TTM)-7.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-8.164M
  • ROE (TTM)-52.76%
  • Revenue (TTM)10.78M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-99.24%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kazia Therapeutics Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Kazia Therapeutics Limited is an Australia-based oncology-focused drug development company. The Company collaborates with clinicians, scientists, and researchers across the world for the development of cancer treatment. The Company’s product candidates include Paxalisib and EVT801. Paxalisib (GDC-0084) is invented by Genentech, Inc (South San Francisco, CA). Genentech, Inc is a developer of new cancer medicines across the world. The Company entered into a license agreement...
Iain Ross
Non-Executive Chairman of the Board
James Garner
Chief Executive Officer, Executive Director
Karen Krumeich
Chief Financial Officer
Address
Three International Towers Level 24
, 300 Barangaroo Avenue
Sydney, NSW
2000
Australia

Top Peers

SYMBOLLASTCHG%CHG
VYNE
Vyne Therapeutics Inc
0.381+0.001+0.26%
CRXT
Clarus Therapeutics Holdings Inc
0.3937+0.0207+5.55%
AVTX
Avalo Therapeutics Inc
0.31+0.0099+3.30%
KALA
Kala Pharmaceuticals Inc
0.3775-0.0225-5.625%
ACUR
Acura Pharmaceuticals Inc
0.53+0.02+3.92%